Answers are grounded in this paper and cite their sources.
BACKGROUNDHistopathological evaluation is essential for differentiating benign from malignant biliary strictures.During endoscopic retrograde cholangiopancreatography (ERCP), tissue sampling relies on intraductal forceps biopsy and brush cytology; however, their diagnostic sensitivity remains suboptimal, partly due to limited tissue acquisition from the stricture site. AIMTo developed a novel reverse biopsy forceps that samples the proximal side of a stricture, and evaluated its feasibility, safety, and potential clinical utility. METHODSThis single-center prospective study enrolled 16 consecutive patients with biliary strictures highly suspected of malignancy who underwent ERCP between November 2024 and August 2025.Brush cytology was performed first at the site of the stricture.reverse biopsy forceps and 75.0%(12/16) for forward biopsy forceps alone.Pathology suggested that tumor heterogeneity contributed to sampling variability and supported the potential complementary value of multi-site sampling with both forceps.Post-ERCP fever occurred in 3 patients and mild pancreatitis in 1, with no serious device-related adverse events. CONCLUSIONReverse biopsy forceps are feasible, safe, and provide high-quality specimens.Combined sampling with forward and reverse biopsy forceps improved the diagnostic yield and may facilitate the evaluation of biliary strictures in practice (registration: ChiCTR2600120019).
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: